GBT | Global Blood Therapeutics Inc.
Category: Consumer goods
Quick infos Headquarters: South San Francisco, California, United States Trade prices Volume: 9.2M Market Cap: 2.14B Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: No Dividends Next ER: August 8, 2022 After Market Closes
Earnings History Date EPS / Forecast Revenue / Forecast November 3, 2022 August 8, 2022 -1.26 / -1.1871.55M / 64.39MBeat! May 4, 2022 -1.26 / -1.3155.16M / 56.04MFebruary 23, 2022 -1.36 / -1.1356.1M / 55.44MBeat! November 4, 2021 -1.13 / -1.1152.05M / 53.69Mview more
Historical Data Date Price Open High Low Vol Change ER Aug 8, 2022 66.60 66.69 66.77
66.54
39.26M 4.32% Aug 5, 2022 63.84 47.17 71.97
46.72
13.98M 33.03% Aug 4, 2022 47.99 44.10 48.49
43.53
8.85M 41.44% Aug 3, 2022 33.93 33.40 34.82
33.38
1.48M 3.04% Aug 2, 2022 32.93 32.34 33.23
32.10
665.52K 1.64% Aug 1, 2022 32.40 31.51 33.65
31.51
891.43K -0.98% Jul 29, 2022 32.72 32.28 32.81
31.59
802.54K -0.03% Jul 28, 2022 32.73 33.86 34.58
32.21
714.01K -3.82% Jul 27, 2022 34.03 33.44 34.42
32.94
1.26M 2.04% Jul 26, 2022 33.35 33.46 34.03
32.43
883.14K -0.51% view more
GBT
More profiles and info about the company News
Global Blood Therapeutics (GBT) Reports Q1 Loss, Lags Revenue Estimates finance.yahoo.com Aug 9, 2022 5:25 pm Stock Market Ends Upbeat Week With Mixed Results On Hot Job Numbers investors.com Aug 9, 2022 4:49 pm
GBT Announces Participation in Upcoming Investor Conferences finance.yahoo.com Aug 9, 2022 4:05 pm
Why Global Blood Therapeutics Stock Is Soaring Today fool.com Aug 9, 2022 2:42 pm
Why Global Blood Therapeutics Stock Is Vaulting Higher Today fool.com Aug 9, 2022 1:35 pm
Pfizer Agrees to $5.4 Billion Deal for Global Blood Therapeutics wsj.com Aug 9, 2022 12:58 pm
Pfizer, Global Blood Therapeutics In Advanced Talks For $5B Buyout Deal: Report finance.yahoo.com Aug 9, 2022 12:20 pm WSJ: Pfizer considering buying Global Blood Therapeutics for roughly $5 billion marketwatch.com Aug 9, 2022 11:58 am
Karunas Schizophrenia-Trial Data Are Best Case Scenario for the Biotech Stock barrons.com Aug 9, 2022 11:48 am
Global Blood (GBT) Q1 Loss Narrower Than Expected, Revenues Lag finance.yahoo.com Aug 9, 2022 10:22 am
Biotech Wins Last Week: 5 Best ETFs finance.yahoo.com Aug 9, 2022 10:05 am
Global Blood Therapeutics' Oxbryta Scores European Approval For Sickle Cell Disease finance.yahoo.com Aug 9, 2022 9:41 am Global Blood Therapeutics shares jump 34% after Bloomberg report about 'takeover interest' marketwatch.com Aug 9, 2022 9:07 am
GBT to Announce First Quarter 2022 Financial Results on Wednesday, May 4, 2022 finance.yahoo.com Aug 9, 2022 8:00 am
GBTs Inclacumab and GBT601 Receive U.S. FDA Orphan Drug and Rare Pediatric Disease Designations for the Treatment of Sickle Cell Disease finance.yahoo.com Aug 9, 2022 8:00 am
Tesla, Palantir, Berkshire Hathaway and More Stock Market Movers Monday barrons.com Aug 9, 2022 7:22 am Pfizer confirms to acquire Global Blood Therapeutics for $5.4 billion in deal that gives it access to sickle-cell disease treatment marketwatch.com Aug 9, 2022 6:52 am Flush with cash, Pfizer buys Global Blood Therapeutics in $5.4 billion deal finance.yahoo.com Aug 9, 2022 6:48 am Why Pfizer's $5.4 Billion GBT Takeover Is 'Mutually Beneficial' investors.com Aug 8, 2022 4:07 pm
GBT Announces Participation at the Wedbush PacGrow Healthcare Conference finance.yahoo.com Aug 3, 2022 4:05 pm This company doesn't provide a dividend.
Key Persons Talk about Global Blood Therapeutics Inc. below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.
